83 results on '"R. Dessein"'
Search Results
2. Faut-il vacciner les femmes enceintes françaises contre la coqueluche ?
- Author
-
H. Hattabi, C. Bouchez, F. Dubos, A. Martinot, K. Faure, R. Dessein, S. Bartolo, and D. Subtil
- Subjects
Reproductive Medicine ,Obstetrics and Gynecology - Published
- 2022
- Full Text
- View/download PDF
3. [Should French pregnant women be vaccinated against pertussis during pregnancy?]
- Author
-
H, Hattabi, C, Bouchez, F, Dubos, A, Martinot, K, Faure, R, Dessein, S, Bartolo, and D, Subtil
- Subjects
Pregnancy ,Whooping Cough ,Cost-Benefit Analysis ,Vaccination ,Infant, Newborn ,Parturition ,Humans ,Infant ,Female ,Pregnant Women ,Child - Abstract
Many countries with a high perinatal level have started a policy of vaccination of pregnant women against pertussis. To date, France has not chosen this policy. The objective was to review knowledge on pertussis mortality in infants. Compare the strategies available to protect the infant before his first vaccination, scheduled for two months of age. We proceeded to a litterature analysis, from January 1998 to 2021. Search by the following keywords used ; "Whooping cough, vaccination, pregnancy, strategy, cocooning", on the scientific basis of "Pubmed", as well as French and foreign vaccination recommendations. Currently 90% of whooping cough deaths are concerning infants under six months of age and this mortality represents 2% of mortality in the first year of life. Vaccination at birth is not effective. The cocooning strategy, which consists of vaccinating those around the child, is expensive and difficult to implement. A systematic vaccination policy for pregnant women is effective and reasonably expensive when compared to the cocooning strategy. In England, it was recently accompanied by a 78% reduction in confirmed cases of pertussis in infants under six months of age. In conclusion, compared to cocooning strategy, pertussis vaccination of pregnant women appears more effective and cost-effective, and this with each pregnancy.
- Published
- 2021
4. Association entre taux de polluants environnementaux et survenue d’asthme aigu de l’enfant dans la métropole lilloise
- Author
-
L.A. Huet, A. Deschildre, E. Drumez, P. Gosset, C. Thumerelle, C. Mordacq, G. Pouessel, M. Pichavant, I. Engelmann, R. Dessein, L. Beghin, F. Dubos, F. Occelli, L. Dauchet, and S. Lejeune
- Subjects
Immunology and Allergy - Published
- 2022
- Full Text
- View/download PDF
5. [Update of Chlamydia trachomatis infection]
- Author
-
C, Debonnet, G, Robin, J, Prasivoravong, F, Vuotto, S, Catteau-Jonard, K, Faure, R, Dessein, and C, Robin
- Subjects
Male ,Pregnancy ,Infertility ,Humans ,Chlamydia trachomatis ,Female ,Chlamydia Infections ,Hysterosalpingography ,Infertility, Female ,Pelvic Inflammatory Disease - Abstract
Chlamydia trachomatis (CT) is the most common sexually transmitted bacterial infection worldwide. It is asymptomatic in most cases and mainly affects young women, with potential long term sequelae (pelvic inflammatory disease, tubal infertility, obstetric complications). The impact on male fertility is controversial. Screening methods as well as antibiotics use have recently been reassessed due to resistance phenomena and the negative effect on the urogenital microbiota. Positive CT serology may be indicative of tuboperitoneal pathology, which may not be noticed on hysterosalpingography. New research on single-nucleotide polymorphisms (SNPs) aims to establish a patient profile at higher risk of infectious tubal damage due to CT. CT seropositivity is also associated with decreased spontaneous pregnancy rates and is a predictive factor for obstetrical complications.
- Published
- 2020
6. [Postpartum endometritis: CNGOF and SPILF Pelvic Inflammatory Diseases Guidelines]
- Author
-
K, Faure, R, Dessein, S, Vanderstichele, and D, Subtil
- Subjects
Fever ,Cesarean Section ,Anticoagulants ,Thrombophlebitis ,Amoxicillin-Potassium Clavulanate Combination ,Pelvic Pain ,Anti-Bacterial Agents ,Postoperative Complications ,Pregnancy ,Risk Factors ,Vagina ,Humans ,Puerperal Infection ,Female ,Endometritis ,Pelvic Inflammatory Disease - Abstract
Postpartum endometritis accounts for 2% of postpartum infections in developed countries. In France, 2.3% of deaths are attributed to puerperal infections. The most important risk factor is cesarean delivery, especially if it is done after the start of labor. Bacteria of the vaginal microbiota are associated with postpartum endometritis. Symptoms are abdomino-pelvic pain, hyperthermia and abnormal lochia. The diagnosis is confirmed by uterine mobilization pain. The first-line antibiotic therapy is amoxicillin-clavulanic acid 3 to 6 grams per day depending on the weight, intravenously or orally. In case of impossibility to use penicillins (anaphylaxis for example), the combination of clindamycin 600mg×4/d plus gentamicin 5mg/kg×1/d may be use, it must be a specialized decision in case of maternal breastfeeding. The treatment is continued until obtaining 48hours of apyrexia and the disappearance of pelvic pain. In case of persistence of fever and/or pelvic pain after 72hours of antibiotic therapy, pelvic imaging should be performed for placental retention, septic thrombophlebitis, deep abscess or any other surgical complication and eliminate differential diagnoses. It is important to highlight the difficulties of interpreting endo-uterine images in ultrasound. Hypocoagulant heparin therapy should be started in case of septic thrombophlebitis for 6 weeks, or longer if there are complications such as embolism or thrombotic risk factors. Regarding prevention, during a caesarean section, a vaginal swab with iodinated polividone or chlorhexidine is recommended before caesarean if possible, and extraction of the placenta must be spontaneous.
- Published
- 2019
7. Les thérapeutiques anti-infectieuses non antibiotiques
- Author
-
R. Dessein, Eric Kipnis, Karine Faure, and Benoit Guery
- Subjects
Gynecology ,medicine.medical_specialty ,business.industry ,Emergency Medicine ,medicine ,Emergency Nursing ,business - Abstract
Dans un contexte ou la resistance aux antibiotiques est un phenomene de plus en plus preoccupant, une analyse systematique des autres options therapeutiques semble fondamentale en pathologie infectieuse. Les anticorps polypuis monoclonaux representent une piste therapeutique majeure avec le developpement d’anticorps diriges contre les systemes de virulence specifiques de certains pathogenes. La modulation du quorum-sensing et des facteurs de virulence en dependant est une approche en plein developpement en pathologie aigue comme dans les infections chroniques. Enfin, les bacteriophages ou les probiotiques peuvent aussi constituer une solution de recours dans divers tableaux infectieux. Cette revue precise les avancees dans chacun de ces domaines de la therapeutique anti-infectieuse non antibiotique.
- Published
- 2012
- Full Text
- View/download PDF
8. [Tubo-ovarian abscesses treatment: Faisability and results of trans-vaginal ultrasound-guided aspiration]
- Author
-
C, Vermersch, R, Dessein, J-P, Lucot, C, Rubod, M, Cosson, and G, Giraudet
- Subjects
Adult ,Adolescent ,Fallopian Tube Diseases ,Middle Aged ,Abscess ,Anti-Bacterial Agents ,Young Adult ,Postoperative Complications ,Treatment Outcome ,Vagina ,Drainage ,Feasibility Studies ,Humans ,Female ,Ovarian Diseases ,Ultrasonography, Interventional - Abstract
Two years after the French guidelines, the objective was to assess the feasibility and efficiency of ultrasound-guided trans-vaginal drainage of tubo-ovarian abscesses (TOA) and to study the responsible germs.All the patients with a larger abscess than 20mm were included prospectively from May 2011 to July 2014 in the university hospital of Lille.Sixty-nine drainages were performed among 50 patients. Success rate was 94%. No complication occurred. One germ was found in 55% of patients, the TOA was polymicrobian in 20% of cases.Ultrasound-guided trans-vaginal drainage of TOA is safe and effective with more than 90% of success rate.
- Published
- 2014
9. [Management of urinary tract infections in children. Evaluation of clinical practice]
- Author
-
S, Bontemps, M, Lagrée, R, Dessein, A, Maftei, A, Martinot, and F, Dubos
- Subjects
Male ,Adolescent ,Age Factors ,Infant, Newborn ,Infant ,Anti-Bacterial Agents ,Clinical Protocols ,Child, Preschool ,Practice Guidelines as Topic ,Urinary Tract Infections ,Humans ,Patient Compliance ,Female ,France ,Guideline Adherence ,Child ,Retrospective Studies - Abstract
To determine the rate of therapeutic management satisfying the institutional protocol for children with urinary tract infection (UTI) in the context of the emergence of extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae.A retrospective, single-center, observational study was carried out for 1 year (2010-2011). Data from all children admitted to the emergency department with a diagnosis of UTI were analysed. Adherence to the protocol was evaluated for the initial management and at re-evaluation with the definitive result of the urine culture. Risk factors for nonadherence were analysed.Among the children, 393 were included. An ESBL Enterobacteriaceae-related UTI was identified in 2.2% of urine analyses. The initial therapeutic management satisfied the protocol for 95% of children and at re-evaluation for 80%. Nonadherence was related to poorly adapted treatment (59%) and an erroneous indication of dual antibiotic therapy (20%). Variables associated with the inadequacy of the initial management were age less than 3 months (adjusted OR [aOR]: 9.3; 95%CI: 3.5-24.8) and at re-evaluation age under 3 months (aOR: 12.8; 95%CI: 5.5-29.9) and an unconfirmed infection in the final urine culture (aOR: 30.8; 14.7-64.3).Adherence to the protocol was good but could be increased by a better re-evaluation procedure with the result of the urine culture. ESBL Enterobacteriaceae-related UTIs were still rare enough to influence the efficacy of management.
- Published
- 2014
10. Les thérapeutiques infectieuses non antibiotiques
- Author
-
E. Kipnis, R. Dessein, K. Faure, and B. Guery
- Published
- 2013
- Full Text
- View/download PDF
11. [Detection of extended-spectrum ß-lactamase-producing Enterobacteriaceae in rectal swabs with the Mastdiscs™ ID AmpC ßLSE detection set]
- Author
-
N, Lemaître, C, Loïez, N, Pastourel, B, Grandbastien, N, Loukili, R, Dessein, and R, Courcol
- Subjects
Microbiological Techniques ,Bacterial Proteins ,Enterobacteriaceae ,Drug Resistance, Multiple, Bacterial ,Klebsiella ,Enterobacter ,Enterobacteriaceae Infections ,Rectum ,Humans ,Microbial Sensitivity Tests ,Reagent Kits, Diagnostic ,beta-Lactamases - Abstract
The double-disk synergy test was compared to the Mastdiscs™ ID AmpC and ESßL method for detection of ESßL production in rectal swab.Two hundred and forty-nine rectal swabs were directly inoculated onto Mueller-Hinton plates and analyzed according to both methods.A total of 41 (16%) and 208 (84%) were positive and negative for ESßL, respectively. Twelve (29%) and 20 (49%) of the 41 rectal swabs positive for ESßL were detected after 24h of incubation with the double-disk synergy test and the Mastdiscs™ method, respectively (P=0.013). One hundred fifty-eight (76%) et 183 (88%) of the 208 rectal swabs were detected negative for ESßL after 24h of incubation with the double-disk synergy test and the Mastdiscs™ method, respectively (P0.001). Finally, 79 (32%) and 46 (18%) rectal swabs respectively inoculated according to the double-disk synergy test and the Mastdiscs™ method were inconclusive after 24h of incubation. The better performance of the Mastdiscs™ method was due to an easier detection of cephalosporinase producing bacteria.The Mastdiscs™ method is a simple phenotypic method that detects more easily ESßL and non-ESßL producing bacteria in rectal swab.
- Published
- 2011
12. Toll-like receptor 2 is critical for induction of Reg3β expression and intestinal clearance of Yersinia pseudotuberculosis.
- Author
-
R Dessein
- Subjects
- *
YERSINIA pseudotuberculosis , *LYMPHADENITIS , *CROHN'S disease , *INFLAMMATION , *ANTIBACTERIAL agents - Abstract
OBJECTIVE: Yersinia pseudotuberculosis causes ileitis and mesenteric lymphadenitis by mainly invading the Peyer’s patches that are positioned in the terminal ileum. Whereas toll-like-receptor 2 (TLR2) controls mucosal inflammation by detecting certain microbiota-derived signals, its exact role in protecting Peyer’s patches against bacterial invasion has not been defined. DESIGN: Wild-type, Tlr2-, Nod2- and MyD88-deficient animals were challenged by Y pseudotuberculosis via the oral or systemic route. The role of microbiota in conditioning Peyer’s patches against Yersinia through TLR2 was assessed by delivering, ad libitum, exogenous TLR2 agonists in drinking water to germ-free and streptomycin-treated animals. Bacterial eradication from Peyer’s patches was measured by using a colony-forming unit assay. Expression of cryptdins and the c-type lectin Reg3β was quantified by quantitative reverse transcriptase polymerase chain reaction analysis. RESULTS: Our data demonstrated that Tlr2-deficient mice failed to limit Yersinia dissemination from the Peyer’s patches and succumbed to sepsis independently of nucleotide-binding and oligomerisation domain 2 (NOD2). Recognition of both microbiota-derived and myeloid differentiation factor 88 (MyD88)-mediated elicitors was found to be critically involved in gut protection against Yersinia-induced lethality, while TLR2 was dispensable to systemic Yersinia infection. Gene expression analyses revealed that optimal epithelial transcript level of the anti-infective Reg3β requires TLR2 activation. Consistently, Yersinia infection triggered TLR2-dependent Reg3β expression in Peyer’s patches. Importantly, oral treatment with exogenous TLR2 agonists in germ-free animals was able to further enhance Yersinia-induced expression of Reg3β and to restore intestinal resistance to Yersinia. Lastly, genetic ablation of Reg3β resulted in impaired clearance of the bacterial load in Peyer’s patches. CONCLUSIONS: TLR2/REG3β is thus an essential component in conditioning epithelial defence signalling pathways against bacterial invasion. [ABSTRACT FROM AUTHOR]
- Published
- 2009
- Full Text
- View/download PDF
13. Trends in influenza vaccination and its determinants among pregnant French women between 2015 and 2020: A single-center study.
- Author
-
Alaoui K, Vanderstichele S, Bartolo S, Hammou Y, Debarge V, Dessein R, Faure K, and Subtil D
- Subjects
- Humans, Female, Pregnancy, France, Adult, Young Adult, Pregnant Women, Influenza Vaccines administration & dosage, Influenza, Human prevention & control, Vaccination statistics & numerical data, Vaccination trends, Pregnancy Complications, Infectious prevention & control
- Abstract
In 2016, only 7% of French women had received an influenza vaccination during their pregnancy. In this vaccine-averse country, the possibility of reaching the rates of 50% observed in other countries remains unknown. To measure the rate of influenza vaccination in a French university maternity. To study its evolution and determinants over the last 5 years. Single-center observational study of all women who gave birth during March 2020 in this maternity. Comparison with rates observed in 2015 in the same conditions. Of the 337 women included in the study, 202 received a vaccination during pregnancy (59.9%). After logistic regression, the factors significantly associated with achieving vaccination were the offer of vaccination during pregnancy, odds ratio (ORa) 26.2 [7.0; 98.2]; previous vaccination, ORa 20.3 [9.6; 42.6]; high education level, ORa 2.9 [1.3; 6.2]; delivery of a CERFA government reimbursement form, ORa 2.5 [1.3; 4.8]; a vaccination offer made by a general practitioner, ORa 2.1 [1.0; 4.4] and not by a hospital midwife, ORa 0.3 [0.1; 0.6]. The rate of vaccination increased from 35% to 59.9% between 2015 and 2020 ( p < .001), with a significant increase in the offer of vaccination during pregnancy (+14.6%) - especially by a general practitioner (+17.2%) - and in the rate of women with earlier vaccination (+13.6%). In France, vaccination rates above 50% are possible at a center level. A proposal of vaccination during pregnancy - especially by the general practitioner - seems to be a determining factor in this development.
- Published
- 2024
- Full Text
- View/download PDF
14. Reassessing the association between bacterial vaginosis and preterm birth: A systematic review and meta-analysis.
- Author
-
Hadhoum S, Subtil D, Labreuche J, Couvreur E, Brabant G, Dessein R, and Le Guern R
- Abstract
Background: For the past three decades, researchers have proposed an association between bacterial vaginosis (BV) and preterm birth. This association has been questioned since treating BV with antibiotics during pregnancy hasn't led to a decreased risk of preterm birth., Objective: To re-assess the connection between BV and preterm birth by reviewing existing literature., Search Strategy: A systematic search was conducted on PubMed and Web of Science using the keywords "bacterial vaginosis" and "preterm birth" up to November 2020. The protocol followed PRISMA guidelines and was registered with PROSPERO (CRD42022337806)., Selection Criteria: Studies were included if they: 1) explored the link BV and preterm birth, 2) used diagnostic criteria based on Nugent, Amsel or Spiegel methods, 3) defined preterm birth at <37, 35, or 32 weeks, and 4) involved patients without impending preterm labor symptoms when sampled., Data Collection and Analysis: Data were extracted and analyzed by region, BV diagnosis method, study period, and quality score., Mains Results: A total of 28 studies were included in the analysis (comprising 50,466 patients). There was a significant link between BV and preterm birth, with an overall OR of 1.60 [95% CI, 1.36-1.89]. Heterogeneity was high (I²=67%). The elevated risk remained consistent across geographic areas, diagnostic procedures, study periods, and study quality scale (Newcastle-Ottawa score)., Conclusion: Our meta-analysis confirms the association between bacterial vaginosis and preterm birth. However, the connection appears to be weaker than previously documented. This observation may offer insight into the ineffectiveness of BV treatments in reducing preterm birth risk., Competing Interests: Declarations of interest None., (Copyright © 2024 Elsevier Masson SAS. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
15. Gut colonisation with multidrug-resistant Klebsiella pneumoniae worsens Pseudomonas aeruginosa lung infection.
- Author
-
Le Guern R, Grandjean T, Stabler S, Bauduin M, Gosset P, Kipnis É, and Dessein R
- Subjects
- Animals, Mice, Male, Klebsiella pneumoniae, Dysbiosis, Mice, Inbred C57BL, Lung, Fatty Acids, Volatile, Pseudomonas aeruginosa, Pseudomonas Infections
- Abstract
Carbapenemase-producing Enterobacterales (CPE) are spreading rapidly in hospital settings. Asymptomatic CPE gut colonisation may be associated with dysbiosis and gut-lung axis alterations, which could impact lung infection outcomes. In this study, in male C57BL/6JRj mice colonised by CPE, we characterise the resulting gut dysbiosis, and analyse the lung immune responses and outcomes of subsequent Pseudomonas aeruginosa lung infection. Asymptomatic gut colonisation by CPE leads to a specific gut dysbiosis and increases the severity of P. aeruginosa lung infection through lower numbers of alveolar macrophages and conventional dendritic cells. CPE-associated dysbiosis is characterised by a near disappearance of the Muribaculaceae family and lower levels of short-chain fatty acids. Faecal microbiota transplantation restores immune responses and outcomes of lung infection outcomes, demonstrating the involvement of CPE colonisation-induced gut dysbiosis in altering the immune gut-lung axis, possibly mediated by microbial metabolites such as short-chain fatty acids., (© 2023. The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF
16. Progressive in vivo development of resistance to cefiderocol in Pseudomonas aeruginosa.
- Author
-
Sadek M, Le Guern R, Kipnis E, Gosset P, Poirel L, Dessein R, and Nordmann P
- Subjects
- Humans, Pseudomonas aeruginosa, Cephalosporins pharmacology, Cephalosporins therapeutic use, beta-Lactamases metabolism, Microbial Sensitivity Tests, Cefiderocol, Anti-Bacterial Agents pharmacology, Anti-Bacterial Agents therapeutic use, Anti-Bacterial Agents metabolism, Pseudomonas Infections drug therapy, Pseudomonas Infections microbiology
- Abstract
We report in vivo development of cefiderocol (FDC) resistance among four sequential Pseudomonas aeruginosa clinical isolates ST244 recovered from a single patient, without exposure to FDC, which raises concern about the effectiveness of this novel drug. The first recovered P. aeruginosa isolate (P-01) was susceptible to FDC (2 μg/mL), albeit this MIC value was higher than that of a wild-type P. aeruginosa (0.12-0.25 μg/ml). The subsequent isolated strains (P-02, P-03, P-04) displayed increasing levels of FDC MICs (8, 16, and 64 μg/ml, respectively). Those isolates also showed variable and gradual increasing levels of resistance to most β-lactams tested in this study. Surprisingly, no acquired β-lactamase was identified in any of those isolates. Whole-genome sequence analysis suggested that this resistance was driven by multifactorial mechanisms including mutational changes in iron transporter proteins associated with FDC uptake, ampC gene overproduction, and mexAB-oprM overexpression. These findings highlight that a susceptibility testing to FDC must be performed prior to any prescription., (© 2022. The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF
17. Characterization of the Achromobacter xylosoxidans Type VI Secretion System and Its Implication in Cystic Fibrosis.
- Author
-
Le Goff M, Vastel M, Lebrun R, Mansuelle P, Diarra A, Grandjean T, Triponney P, Imbert G, Gosset P, Dessein R, Garnier F, and Durand E
- Subjects
- Ecosystem, Humans, Lung, Virulence Factors genetics, Achromobacter denitrificans genetics, Cystic Fibrosis complications, Cystic Fibrosis microbiology, Gram-Negative Bacterial Infections microbiology, Type VI Secretion Systems genetics
- Abstract
Bacteria of the genus Achromobacter are environmental germs, with an unknown reservoir. It can become opportunistic pathogens in immunocompromised patients, causing bacteremia, meningitis, pneumonia, or peritonitis. In recent years, Achromobacter xylosoxidans has emerged with increasing incidence in patients with cystic fibrosis (CF). Recent studies showed that A. xylosoxidans is involved in the degradation of the respiratory function of patients with CF. The respiratory ecosystem of patients with CF is colonized by bacterial species that constantly fight for space and access to nutrients. The type VI secretion system (T6SS) empowers this constant bacterial antagonism, and it is used as a virulence factor in several pathogenic bacteria. This study aimed to investigate the prevalence of the T6SS genes in A. xylosoxidans isolated in patients with CF. We also evaluated clinical and molecular characteristics of T6SS-positive A. xylosoxidans strains. We showed that A. xylosoxidans possesses a T6SS gene cluster and that some environmental and clinical isolates assemble a functional T6SS nanomachine . A. xylosoxidans T6SS is used to target competing bacteria, including other CF-specific pathogens. Finally, we demonstrated the importance of the T6SS in the internalization of A. xylosoxidans in lung epithelial cells and that the T6SS protein Hcp is detected in the sputum of patients with CF. Altogether, these results suggest for the first time a role of T6SS in CF-lung colonization by A. xylosoxidans and opens promising perspective to target this virulence determinant as innovative theranostic options for CF management., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2022 Le Goff, Vastel, Lebrun, Mansuelle, Diarra, Grandjean, Triponney, Imbert, Gosset, Dessein, Garnier and Durand.)
- Published
- 2022
- Full Text
- View/download PDF
18. [Should French pregnant women be vaccinated against pertussis during pregnancy?]
- Author
-
Hattabi H, Bouchez C, Dubos F, Martinot A, Faure K, Dessein R, Bartolo S, and Subtil D
- Subjects
- Child, Cost-Benefit Analysis, Female, Humans, Infant, Infant, Newborn, Parturition, Pregnancy, Pregnant Women, Vaccination, Whooping Cough prevention & control
- Abstract
Many countries with a high perinatal level have started a policy of vaccination of pregnant women against pertussis. To date, France has not chosen this policy. The objective was to review knowledge on pertussis mortality in infants. Compare the strategies available to protect the infant before his first vaccination, scheduled for two months of age. We proceeded to a litterature analysis, from January 1998 to 2021. Search by the following keywords used ; "Whooping cough, vaccination, pregnancy, strategy, cocooning", on the scientific basis of "Pubmed", as well as French and foreign vaccination recommendations. Currently 90% of whooping cough deaths are concerning infants under six months of age and this mortality represents 2% of mortality in the first year of life. Vaccination at birth is not effective. The cocooning strategy, which consists of vaccinating those around the child, is expensive and difficult to implement. A systematic vaccination policy for pregnant women is effective and reasonably expensive when compared to the cocooning strategy. In England, it was recently accompanied by a 78% reduction in confirmed cases of pertussis in infants under six months of age. In conclusion, compared to cocooning strategy, pertussis vaccination of pregnant women appears more effective and cost-effective, and this with each pregnancy., (Copyright © 2022 Elsevier Masson SAS. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
19. Answer to January 2022 Photo Quiz.
- Author
-
Sermet K, Kipnis E, Duployez C, Wallet F, Dessein R, and Le Guern R
- Published
- 2022
- Full Text
- View/download PDF
20. Photo Quiz: Gram-Variable Staining in Anaerobic Bacteremia.
- Author
-
Sermet K, Kipnis E, Duployez C, Wallet F, Dessein R, and Le Guern R
- Published
- 2022
- Full Text
- View/download PDF
21. Colonization resistance against multi-drug-resistant bacteria: a narrative review.
- Author
-
Le Guern R, Stabler S, Gosset P, Pichavant M, Grandjean T, Faure E, Karaca Y, Faure K, Kipnis E, and Dessein R
- Subjects
- Anti-Bacterial Agents pharmacology, Anti-Bacterial Agents therapeutic use, Drug Resistance, Multiple, Bacterial, Dysbiosis, Humans, Gastrointestinal Microbiome, Pharmaceutical Preparations
- Abstract
Colonization resistance by gut microbiota is a fundamental phenomenon in infection prevention and control. Hospitalized patients may be exposed to multi-drug-resistant bacteria when hand hygiene compliance among healthcare workers is not adequate. An additional layer of defence is provided by the healthy gut microbiota, which helps clear the exogenous bacteria and acts as a safety net when hand hygiene procedures are not followed. This narrative review focuses on the role of the gut microbiota in colonization resistance against multi-drug-resistant bacteria, and its implications for infection control. The review discusses the underlying mechanisms of colonization resistance (direct or indirect), the concept of resilience of the gut microbiota, the link between the antimicrobial spectrum and gut dysbiosis, and possible therapeutic strategies. Antimicrobial stewardship is crucial to maximize the effects of colonization resistance. Avoiding unnecessary antimicrobial therapy, shortening the antimicrobial duration as much as possible, and favouring antibiotics with low anti-anaerobe activity may decrease the acquisition and expansion of multi-drug-resistant bacteria. Even after antimicrobial therapy, the resilience of the gut microbiota often occurs spontaneously. Spontaneous resilience explains the existence of a window of opportunity for colonization of multi-drug-resistant bacteria during or just after antimicrobial therapy. Strategies favouring resilience of the gut microbiota, such as high-fibre diets or precision probiotics, should be evaluated., (Copyright © 2021 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
22. [Update of Chlamydia trachomatis infection].
- Author
-
Debonnet C, Robin G, Prasivoravong J, Vuotto F, Catteau-Jonard S, Faure K, Dessein R, and Robin C
- Subjects
- Chlamydia trachomatis, Female, Humans, Hysterosalpingography, Male, Pregnancy, Chlamydia Infections complications, Chlamydia Infections diagnosis, Infertility, Infertility, Female etiology, Pelvic Inflammatory Disease
- Abstract
Chlamydia trachomatis (CT) is the most common sexually transmitted bacterial infection worldwide. It is asymptomatic in most cases and mainly affects young women, with potential long term sequelae (pelvic inflammatory disease, tubal infertility, obstetric complications). The impact on male fertility is controversial. Screening methods as well as antibiotics use have recently been reassessed due to resistance phenomena and the negative effect on the urogenital microbiota. Positive CT serology may be indicative of tuboperitoneal pathology, which may not be noticed on hysterosalpingography. New research on single-nucleotide polymorphisms (SNPs) aims to establish a patient profile at higher risk of infectious tubal damage due to CT. CT seropositivity is also associated with decreased spontaneous pregnancy rates and is a predictive factor for obstetrical complications., (Copyright © 2021 Elsevier Masson SAS. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
23. Comparison of time-to-positivity between two blood culture systems: a detailed analysis down to the genus-level.
- Author
-
Le Guern R, Titécat M, Loïez C, Duployez C, Wallet F, and Dessein R
- Subjects
- Automation, Bacteria classification, Bacteria isolation & purification, Bacteriological Techniques, Charcoal, Culture Media, Humans, Microspheres, Time Factors, Bacteremia diagnosis, Blood Culture methods
- Abstract
A recently developed, automated blood culture system and medium improve the time-to-positivity (TTP) for bacteremia. However, there have thus far been no genus-level analyses using this novel system. We evaluated and compared the changes in blood culture TTP between two systems: BacT/Alert 3D with a blood culture medium containing activated charcoal versus the more recent BacT/Alert Virtuo with a blood culture medium containing polymeric beads. This before-and-after study included blood cultures collected between July 2010 and April 2014 (3D, activated charcoal) and between July 2015 and April 2018 (Virtuo, polymeric beads). A total of 554,732 blood cultures were included, 267,935 (48.30%) during the first period and 286,797 (51.70%) during the second period. Overall, 55,611 (10.02%) tested positive for at least one microorganism. The incubation of the blood culture medium in the Virtuo system was associated with reduced TTP for the most prevalent bacteria, those representing 91.72% (n=51,006) of all the positive blood cultures. The median TTP was reduced by 0.99 h for Staphylococcus, Enterococcus, Streptococcus, Pseudomonadales, and most of the genera within the order Enterobacterales (except the family Morganellaceae). However, strictly anaerobic bacteria belonging to the genus Bacteroides, representing 0.85% (n=474) of all positive blood cultures, were detected 4.53 h later using the Virtuo system. Virtuo was associated with a shorter TTP for most bacteria, but this improvement was heterogeneous to the genus level.
- Published
- 2021
- Full Text
- View/download PDF
24. The Brief Case: Mycoplasma hominis Extragenital Abscess.
- Author
-
Stabler S, Faure E, Duployez C, Wallet F, Dessein R, and Le Guern R
- Subjects
- Abscess diagnosis, Humans, Surgical Wound Infection, Mycoplasma Infections diagnosis, Mycoplasma hominis genetics
- Published
- 2021
- Full Text
- View/download PDF
25. Closing the Brief Case: Mycoplasma hominis Extragenital Abscess.
- Author
-
Stabler S, Faure E, Duployez C, Wallet F, Dessein R, and Le Guern R
- Published
- 2021
- Full Text
- View/download PDF
26. Classification and Regression Trees for Bacterial Vaginosis Diagnosis in Pregnant Women Based on High-Throughput Quantitative PCR.
- Author
-
Loquet A, Le Guern R, Grandjean T, Duployez C, Bauduin M, Kipnis E, Brabant G, Subtil D, and Dessein R
- Subjects
- Adult, Female, Humans, Regression Analysis, Vaginosis, Bacterial microbiology, Pregnant Women, Real-Time Polymerase Chain Reaction methods, Vaginosis, Bacterial diagnosis
- Abstract
Bacterial vaginosis (BV) diagnosis in pregnancy is based on the Nugent score, which consists of semiquantitation of bacterial morphotypes. Limited data exist concerning molecular-based diagnosis in asymptomatic pregnant women. Using high-throughput quantitative PCR, 34 microorganisms were screened in asymptomatic pregnant women and compared with the Nugent score. Three-hundred and four vaginal samples had a Nugent score <7 (69.9%) and 131, a Nugent score ≥7 (30.1%), consistent with BV. More pregnant women with BV share Atopobiumvaginae, bacterial vaginosis associated bacteria-2, Gardnerella spp., Mobiluncus curtisii, Mo. mulieris, Mycoplasma hominis, Ureaplasma urealyticum, Prevotella bivia, Megasphaera 1, and Megasphaera 2 in their vaginal sample. Fewer pregnant women with BV share Lactobacillus crispatus, L. gasseri, L. jensenii, and Enterococcus faecalis in their vaginal sample (P < 0.001). Classification and regression tree analysis was performed to determine which combinations of detected bacteria optimally diagnose BV in this population. A set of only four bacteria of 34 microorganisms (A. vaginae, Gardnerella spp., L. crispatus, and P. bivia) was the best combination to identify BV in a cohort of asymptomatic pregnant women, with a sensitivity of 77.1%, and specificity of 97.0% compared with the Nugent score. The quantitative PCR in the present study responds to the limits of the Nugent score by implementing an easily reproducible quantitative assay to assess the absence of BV in pregnancy., (Copyright © 2021 Association for Molecular Pathology and American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
27. Spontaneous decolonization during hospitalization in intensive care unit patients colonized by extended-spectrum beta-lactamase-producing Enterobacterales.
- Author
-
Duployez C, Wallet F, Rouzé A, Nseir S, Kipnis E, El Kalioubie A, Dessein R, Loïez C, and Le Guern R
- Subjects
- Aged, Carrier State epidemiology, Cross Infection epidemiology, Enterobacteriaceae enzymology, Enterobacteriaceae Infections microbiology, Enterobacteriaceae Infections transmission, Female, Hospitalization, Humans, Male, Middle Aged, Retrospective Studies, beta-Lactamases, Enterobacteriaceae physiology, Enterobacteriaceae Infections prevention & control, Infection Control methods, Intensive Care Units statistics & numerical data, Rectum microbiology
- Abstract
This study aimed to analyse the frequency of occurrence of spontaneous decolonization in intensive care unit patients colonized by extended-spectrum beta-lactamase-producing Enterobacterales (ESBL-E) in order to assess the added value of continuing weekly ESBL-E rectal carriage screening in these patients. In total, 49,468 weekly rectal screening samples taken from 20,846 patients over 12 years were included. Among the 4280 ESBL-E carriers, only 109 patients (2.5%) could be considered decolonized at the end of their hospitalization with at least three consecutive negative samples. Overall, 7957 samples (16.1%) were requested for patients already identified as ESBL-E carriers. Avoiding unnecessary weekly screening following positive ESBL-E colonization results could decrease nursing and laboratory work loads., (Copyright © 2020 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
28. Antibiotic-related gut dysbiosis induces lung immunodepression and worsens lung infection in mice.
- Author
-
Dessein R, Bauduin M, Grandjean T, Le Guern R, Figeac M, Beury D, Faure K, Faveeuw C, Guery B, Gosset P, and Kipnis E
- Subjects
- Animals, Anti-Bacterial Agents pharmacology, Disease Models, Animal, Dysbiosis etiology, Dysbiosis physiopathology, Immunosuppression Therapy methods, Lung microbiology, Lung physiopathology, Mice, Inbred C57BL, Microbiota drug effects, Pneumonia physiopathology, Pseudomonas aeruginosa drug effects, Vancomycin adverse effects, Vancomycin pharmacology, Anti-Bacterial Agents adverse effects, Dysbiosis complications, Immunosuppression Therapy adverse effects, Pneumonia etiology
- Abstract
Background: Gut dysbiosis due to the adverse effects of antibiotics affects outcomes of lung infection. Previous murine models relied on significant depletion of both gut and lung microbiota, rendering the analysis of immune gut-lung cross-talk difficult. Here, we study the effects of antibiotic-induced gut dysbiosis without lung dysbiosis on lung immunity and the consequences on acute P. aeruginosa lung infection., Methods: C57BL6 mice received 7 days oral vancomycin-colistin, followed by normal regimen or fecal microbial transplant or Fms-related tyrosine kinase 3 ligand (Flt3-Ligand) over 2 days, and then intra-nasal P. aeruginosa strain PAO1. Gut and lung microbiota were studied by next-generation sequencing, and lung infection outcomes were studied at 24 h. Effects of vancomycin-colistin on underlying immunity and bone marrow progenitors were studied in uninfected mice by flow cytometry in the lung, spleen, and bone marrow., Results: Vancomycin-colistin administration induces widespread cellular immunosuppression in both the lung and spleen, decreases circulating hematopoietic cytokine Flt3-Ligand, and depresses dendritic cell bone marrow progenitors leading to worsening of P. aeruginosa lung infection outcomes (bacterial loads, lung injury, and survival). Reversal of these effects by fecal microbial transplant shows that these alterations are related to gut dysbiosis. Recombinant Flt3-Ligand reverses the effects of antibiotics on subsequent lung infection., Conclusions: These results show that gut dysbiosis strongly impairs monocyte/dendritic progenitors and lung immunity, worsening outcomes of P. aeruginosa lung infection. Treatment with a fecal microbial transplant or immune stimulation by Flt3-Ligand both restore lung cellular responses to and outcomes of P. aeruginosa following antibiotic-induced gut dysbiosis.
- Published
- 2020
- Full Text
- View/download PDF
29. Childhood asthma heterogeneity at the era of precision medicine: Modulating the immune response or the microbiota for the management of asthma attack.
- Author
-
Lejeune S, Deschildre A, Le Rouzic O, Engelmann I, Dessein R, Pichavant M, and Gosset P
- Subjects
- Adaptive Immunity, Adjuvants, Immunologic pharmacology, Allergens immunology, Antiviral Agents immunology, Antiviral Agents pharmacology, Asthma immunology, Asthma virology, Biological Products pharmacology, Child, Dysbiosis complications, Humans, Immunity, Innate, Inflammation complications, Inflammation drug therapy, Machine Learning, Asthma drug therapy, Asthma etiology, Microbiota, Precision Medicine methods
- Abstract
Exacerbations are a main characteristic of asthma. In childhood, the risk is increasing with severity. Exacerbations are a strong phenotypic marker, particularly of severe and therapy-resistant asthma. These early-life events may influence the evolution and be involved in lung function decline. In children, asthma attacks are facilitated by exposure to allergens and pollutants, but are mainly triggered by microbial agents. Multiple studies have assessed immune responses to viruses, and to a lesser extend bacteria, during asthma exacerbation. Research has identified impairment of innate immune responses in children, related to altered pathogen recognition, interferon release, or anti-viral response. Influence of this host-microbiota dialog on the adaptive immune response may be crucial, leading to the development of biased T helper (Th)2 inflammation. These dynamic interactions may impact the presentations of asthma attacks, and have long-term consequences. The aim of this review is to synthesize studies exploring immune mechanisms impairment against viruses and bacteria promoting asthma attacks in children. The potential influence of the nature of infectious agents and/or preexisting microbiota on the development of exacerbation is also addressed. We then discuss our understanding of how these diverse host-microbiota interactions in children may account for the heterogeneity of endotypes and clinical presentations. Finally, improving the knowledge of the pathophysiological processes induced by infections has led to offer new opportunities for the development of preventive or curative therapeutics for acute asthma. A better definition of asthma endotypes associated with precision medicine might lead to substantial progress in the management of severe childhood asthma., Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2020 Elsevier Inc. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
30. Severe preschool asthmatics have altered cytokine and anti-viral responses during exacerbation.
- Author
-
Lejeune S, Pichavant M, Engelmann I, Béghin L, Drumez E, Le Rouzic O, Dessein R, Rogeau S, Beke T, Kervoaze G, Delvart C, Ducoin H, Pouessel G, Le Mée A, Boileau S, Roussel J, Bonnel C, Mordacq C, Thumerelle C, Gosset P, and Deschildre A
- Subjects
- Child, Preschool, Humans, Prospective Studies, Respiratory Sounds, Rhinovirus, Asthma, Cytokines
- Abstract
Background: Preschool asthma/recurrent wheeze is a heterogeneous condition. Different clinical phenotypes have been described, including episodic viral wheeze (EVW), severe intermittent wheeze (SIW), and multiple-trigger wheeze (MTW)., Objective: To compare clinical, viral, and inflammatory/immune profiling at exacerbation between MTW, SIW, and EVW phenotypes., Methods: Multicenter, prospective, observational cohort (VIRASTHMA-2). Children (1-5 years) with preschool asthma were enrolled during hospitalization for a severe exacerbation. History and anamnestic data, plasma, and nasal samples were collected at exacerbation (T1) and at steady state, 8 weeks later (T2), and sputum samples were collected at T1., Results: A total of 147 children were enrolled, 37 (25%) had SIW, 18 (12.2%) EVW, and 92 (63%) MTW. They were atopic (47%), exposed to mold (22%) and cigarette smoke (50%), and prone to exacerbations (≥2 in the previous year in 70%). At exacerbation, at least one virus was isolated in 94% and rhinovirus in 75%, with no difference between phenotypes. Children with MTW and SIW phenotypes displayed lower plasma concentrations of IFN-γ (P = .002), IL-5 (P = .020), TNF-α (P = .038), IL-10 (P = .002), IFN-β (P = .036), and CXCL10 (P = .006) and lower levels of IFN-γ (P = .047) in sputum at exacerbation than children with EVW. At T2, they also displayed lower plasma levels of IFN-γ (P = .045) and CXCL10 (P = .013)., Conclusion: Among preschool asthmatic children, MTW and SIW, prone to exacerbations, display lower systemic levels of Th1, Th2 cytokines, pro- and anti-inflammatory cytokines, and antiviral responses during severe virus-induced exacerbation., (© 2020 EAACI and John Wiley and Sons A/S. Published by John Wiley and Sons Ltd.)
- Published
- 2020
- Full Text
- View/download PDF
31. Determinants of pregnant women's knowledge about influenza and the influenza vaccine: A large, single-centre cohort study.
- Author
-
Bartolo S, Mancel O, Deliege E, Carpentier S, Dessein R, Faure K, and Subtil D
- Subjects
- Adult, Cohort Studies, Female, Humans, Pregnancy, Pregnant Women, Prospective Studies, Surveys and Questionnaires, Vaccination statistics & numerical data, Young Adult, Health Knowledge, Attitudes, Practice, Influenza Vaccines, Influenza, Human, Pregnancy Complications etiology
- Abstract
Introduction: Although influenza can lead to adverse outcomes during pregnancy, the level of influenza vaccine coverage among pregnant women remains very low. According to the literature, a high level of knowledge about influenza disease and the influenza vaccine is one of the main determinants of vaccination coverage. The objective of the present study was to describe pregnant women's level of knowledge of these topics and to identify any corresponding determinants., Material and Methods: A prospective, observational, hospital-based study of women having given birth in our university medical centre during the 2014-2015 influenza season. Data were collected through a self-questionnaire or extracted from medical records. Determinants of highest knowledge were identified using logistic regression., Results: Of the 2069 women included in the study, 827 (40%) did not know that influenza can lead to severe adverse outcomes for the mother, and 960 (46%) did not know about possible severe adverse outcomes for the baby. Two hundred and one women (9.8%) stated that the vaccine was "contraindicated" or "unnecessary" during pregnancy. Only 205 women (17%) had been vaccinated during a previous pregnancy. Determinants of the highest level of knowledge were age over 24, a high educational level, previous influenza vaccination, nulliparity, and the recommendation of vaccination by a healthcare professional., Conclusions: Recommending vaccination during pregnancy appears to increase knowledge about influenza and its vaccine among pregnant women., Competing Interests: The authors have declared that no competing interests exist.
- Published
- 2020
- Full Text
- View/download PDF
32. Clinical relevance of Clostridium bacteremia: An 8-year retrospective study.
- Author
-
Stabler S, Titécat M, Duployez C, Wallet F, Loïez C, Bortolotti P, Faure E, Faure K, Kipnis E, Dessein R, and Le Guern R
- Subjects
- Adult, Aged, Anti-Bacterial Agents therapeutic use, Clostridium drug effects, Clostridium perfringens drug effects, Clostridium perfringens isolation & purification, Cohort Studies, Female, Humans, Hypothermia microbiology, Male, Middle Aged, Mortality, Retrospective Studies, Risk Factors, Bacteremia drug therapy, Bacteremia epidemiology, Clostridium isolation & purification, Clostridium Infections drug therapy, Clostridium Infections mortality
- Abstract
Clostridium spp. are recovered from 25% of the blood culture positive with anaerobes. However, the clinical relevance of Clostridium bacteremia has been controverted in the literature, particularly for C. perfringens. We aimed to evaluate the clinical relevance of Clostridium bacteremia, either due to C. perfringens or other Clostridium species, and to identify the risk factors of mortality in these patients. A retrospective cohort study was conducted from January 2010 to April 2018. All the patients with at least one blood culture positive with any Clostridium species were included. Eighty-one patients with a least one blood culture positive with any Clostridium species were included. Seventy patients (86.4%) fulfilled the criteria for clinically relevant bacteremia. Bacteremia due to C. perfringens tended to be less clinically relevant than other Clostridium species but this was not statistically significant (76% vs 91.2%, P = 0.09). In case of clinically relevant bacteremia, the 30-day mortality rate was 31.4%. In multivariate analysis, adequate empiric antimicrobial therapy was significantly associated with survival (P = 0.03). In conclusion, bacteremia due to C. perfringens or other Clostridium species is usually clinically relevant. This finding was also supported by an improved survival at 30 days when adequate empiric antimicrobial therapy was administered., Competing Interests: Declaration of competing interest No conflict of interest., (Copyright © 2020 Elsevier Ltd. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
33. Determinants of influenza vaccination uptake in pregnancy: a large single-Centre cohort study.
- Author
-
Bartolo S, Deliege E, Mancel O, Dufour P, Vanderstichele S, Roumilhac M, Hammou Y, Carpentier S, Dessein R, Subtil D, and Faure K
- Subjects
- Adult, Female, France, Health Expenditures, Humans, Logistic Models, Parity, Patient Education as Topic, Pregnancy, Prenatal Care, Prospective Studies, Young Adult, Health Knowledge, Attitudes, Practice, Influenza Vaccines therapeutic use, Influenza, Human prevention & control, Patient Compliance, Pregnant Women
- Abstract
Background: Although vaccination of pregnant women against influenza is recommended, the vaccination rate remains low. We conducted a study to identify determinants of influenza vaccination uptake in pregnancy in order to identify strategies to improve seasonal influenza vaccination rates., Methods: Prospective observational hospital-based study in the French hospital performing the highest number of deliveries, located in the city of Lille, among all women who had given birth during the 2014-2015 influenza season. Data were collected through a self-completed questionnaire and from medical files. The vaccination uptake was self-reported. Determinants of vaccination uptake were identified using logistic regression analysis., Results: Of the 2045 women included in the study, 35.5% reported that they had been vaccinated against influenza during their pregnancy. The principal factors significantly associated with greater vaccination uptake were previous influenza vaccination (50.9% vs 20.2%, OR 4.1, 95% CI 3.1-5.5), nulliparity (41.0% vs 31.3%, OR 2.5, 95% CI 1.7-3.7), history of preterm delivery < 34 weeks (43.4% vs 30.3%, OR 2.3, 95% CI 1.1-4.9), the mother's perception that the frequency of vaccine complications for babies is very low (54.6% vs 20.6%, OR 1.1, 95% CI 0.5-2.2), the mother's good knowledge of influenza and its vaccine (61.7% vs 24.4%, OR 3.1, 95% CI 2.2-4.4), hospital-based prenatal care in their first trimester of pregnancy (55.0% vs 30.2%, OR 2.1, 95% CI 1.2-3.7), vaccination recommendations during pregnancy by a healthcare worker (47.0% vs 2.7%, OR 18.8, 95% CI 10.0-35.8), receipt of a vaccine reimbursement form (52.4% vs 18.6%, OR 2.0, 95% CI 1.5-2.7), and information from at least one healthcare worker about the vaccine (43.8% vs 19.1%, OR 1.8, 95% CI 1.3-2.6)., Conclusions: Our findings suggest that in order to increase flu vaccination compliance among pregnant women, future public health programmes must ensure cost-free access to vaccination, and incorporate education about the risks of influenza and the efficacy/safety of vaccination and clear recommendations from healthcare professionals into routine antenatal care.
- Published
- 2019
- Full Text
- View/download PDF
34. Clostridium ventriculi bacteremia following acute colonic pseudo-obstruction: A case report.
- Author
-
Bortolotti P, Kipnis E, Faure E, Faure K, Wacrenier A, Fauquembergue M, Penven M, Messaadi S, Marceau L, Dessein R, and Le Guern R
- Subjects
- Aged, Bacteremia microbiology, Clostridium Infections microbiology, Humans, Male, Bacteremia diagnosis, Bacteremia pathology, Clostridium isolation & purification, Clostridium Infections diagnosis, Clostridium Infections pathology, Colonic Pseudo-Obstruction complications
- Abstract
Clostridium ventriculi (formerly Sarcina ventriculi) is a Gram-positive, obligate anaerobic coccus. Human infections due to this bacterium have rarely been reported, its involvement in the development of gastric ulcers and perforation has been suggested. We present a case of bacteremia due to C. ventriculi following acute colonic pseudo-obstruction., (Copyright © 2019 Elsevier Ltd. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
35. Recurrent Pneumococcal Meningitis in Children: A Multicenter Case-control Study.
- Author
-
Darmaun L, Levy C, Lagrée M, Béchet S, Varon E, Dessein R, Cohen R, Martinot A, and Dubos F
- Subjects
- Anti-Bacterial Agents therapeutic use, Case-Control Studies, Cerebrospinal Fluid Leak etiology, Child, Child, Preschool, Female, Humans, Infant, Male, Meningitis, Pneumococcal cerebrospinal fluid, Meningitis, Pneumococcal drug therapy, Recurrence, Retrospective Studies, Streptococcus pneumoniae, Meningitis, Pneumococcal microbiology
- Abstract
Background: Pneumococcal meningitis (PM) is a serious disease that can rarely recur at a later time after the initial episode., Methods: A retrospective multicenter case-control study was conducted with data for children 18 years of age or younger obtained from the National Observatory of Bacterial Meningitis in Children between January 2001 and September 2015. Cases were all patients with RPM. Each case was matched with 2 randomized controls with a single PM episode in the year of the first episode of PM in the case and born the same year. Case and control data were compared., Results: Among the 1634 PM episodes in children 18 years of age or younger, 24 (1.5%) children had RPM. RPM cases were significantly less frequent than single PM cases in winter (27% vs. 48%; P=0.03) and showed significantly less concomitant ear, nose and throat infections when considering the first episode (30% vs. 56%, P = 0.04) and all episodes (28% vs. 56%, P < 0.01). Cerebrospinal fluid leakage was frequent in RPM cases versus controls (83% vs. 10%, P < 0.01), including 25% discovered after the third PM episode. Immune deficiency was absent in cases and present in 15% of controls. Cases and controls did not differ in death rate or neurologic outcome., Conclusions: RPM is rare in children. Cerebrospinal fluid leakage must be considered.
- Published
- 2019
- Full Text
- View/download PDF
36. Differential risk of severe infection in febrile neutropenia among children with blood cancer or solid tumor.
- Author
-
Delebarre M, Dessein R, Lagrée M, Mazingue F, Sudour-Bonnange H, Martinot A, and Dubos F
- Subjects
- Adolescent, Age Factors, Child, Child, Preschool, Female, France epidemiology, Hospitalization, Humans, Infections diagnosis, Male, Public Health Surveillance, Risk Assessment, Risk Factors, Severity of Illness Index, Febrile Neutropenia epidemiology, Febrile Neutropenia etiology, Hematologic Neoplasms complications, Hematologic Neoplasms epidemiology, Infections epidemiology, Infections etiology, Neoplasms complications, Neoplasms epidemiology
- Abstract
Objective: To describe and analyze the differences between infections in children with febrile neutropenia (FN) treated for solid tumor or blood cancer., Methods: A prospective study included all episodes of FN in children from April 2007 to April 2016 in 2-pediatric cancer centers in France. Medical history, clinical and laboratory data available at admission and final microbiological data were collected. The proportion of FN, severe infection, categories of microorganisms and outcomes were compared between the two groups. The presumed gateway of the infection was a posteriori considered and evaluated., Results: We analyzed 1197 FN episodes (mean age: 8 years). 66% of the FN episodes occurred in children with blood cancer. Severe infections were identified in 23.4% of episodes overall. The rate of severe infection (28.4% vs. 10.4%), types of microorganisms and the need for a management in intensive care unit (2.6% vs. 0.5%) was significantly different between children with blood cancer and solid tumor. Digestive or respiratory presumed gateway of the infections was less frequent for patients with solid tumor., Conclusion: Given these important microbiological and clinical differences, it may be appropriate to consider differently the risk of severe infection in these two populations and therefore the management of FN., (Copyright © 2019 The British Infection Association. Published by Elsevier Ltd. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
37. Impact of the Timing of Antibiotic Administration on Digestive Colonization with Carbapenemase-Producing Enterobacteriaceae in a Murine Model.
- Author
-
Le Guern R, Grandjean T, Bauduin M, Figeac M, Millot G, Loquet A, Faure K, Kipnis E, and Dessein R
- Subjects
- Animals, Disease Models, Animal, Enterobacteriaceae metabolism, Infection Control methods, Klebsiella pneumoniae drug effects, Klebsiella pneumoniae metabolism, Mice, Microbial Sensitivity Tests methods, Anti-Bacterial Agents administration & dosage, Bacterial Proteins metabolism, Enterobacteriaceae drug effects, Enterobacteriaceae Infections drug therapy, Gastrointestinal Microbiome drug effects, beta-Lactamases metabolism
- Abstract
While antibiotic use is a risk factor of carbapenemase-producing Enterobacteriaceae (CPE) acquisition, the importance of timing of antibiotic administration relative to CPE exposure remains unclear. In a murine model of gut colonization by New Delhi metallo-beta-lactamase-1 (NDM-1)-producing Klebsiella pneumoniae , a single injection of clindamycin within at most 1 week before or after CPE exposure induced colonization persisting up to 100 days. The timing of antibiotic administration relative to CPE exposure may be relevant to infection control and antimicrobial stewardship approaches., (Copyright © 2019 American Society for Microbiology.)
- Published
- 2019
- Full Text
- View/download PDF
38. [Postpartum endometritis: CNGOF and SPILF Pelvic Inflammatory Diseases Guidelines].
- Author
-
Faure K, Dessein R, Vanderstichele S, and Subtil D
- Subjects
- Amoxicillin-Potassium Clavulanate Combination therapeutic use, Anti-Bacterial Agents therapeutic use, Anticoagulants therapeutic use, Cesarean Section adverse effects, Female, Fever, Humans, Pelvic Pain, Postoperative Complications diagnosis, Postoperative Complications drug therapy, Pregnancy, Puerperal Infection, Risk Factors, Thrombophlebitis diagnosis, Thrombophlebitis drug therapy, Vagina microbiology, Endometritis diagnosis, Endometritis drug therapy, Endometritis microbiology, Pelvic Inflammatory Disease diagnosis, Pelvic Inflammatory Disease drug therapy, Pelvic Inflammatory Disease microbiology
- Abstract
Postpartum endometritis accounts for 2% of postpartum infections in developed countries. In France, 2.3% of deaths are attributed to puerperal infections. The most important risk factor is cesarean delivery, especially if it is done after the start of labor. Bacteria of the vaginal microbiota are associated with postpartum endometritis. Symptoms are abdomino-pelvic pain, hyperthermia and abnormal lochia. The diagnosis is confirmed by uterine mobilization pain. The first-line antibiotic therapy is amoxicillin-clavulanic acid 3 to 6 grams per day depending on the weight, intravenously or orally. In case of impossibility to use penicillins (anaphylaxis for example), the combination of clindamycin 600mg×4/d plus gentamicin 5mg/kg×1/d may be use, it must be a specialized decision in case of maternal breastfeeding. The treatment is continued until obtaining 48hours of apyrexia and the disappearance of pelvic pain. In case of persistence of fever and/or pelvic pain after 72hours of antibiotic therapy, pelvic imaging should be performed for placental retention, septic thrombophlebitis, deep abscess or any other surgical complication and eliminate differential diagnoses. It is important to highlight the difficulties of interpreting endo-uterine images in ultrasound. Hypocoagulant heparin therapy should be started in case of septic thrombophlebitis for 6 weeks, or longer if there are complications such as embolism or thrombotic risk factors. Regarding prevention, during a caesarean section, a vaginal swab with iodinated polividone or chlorhexidine is recommended before caesarean if possible, and extraction of the placenta must be spontaneous., (Copyright © 2019 CNGOF, SPILF. Published by Elsevier Masson SAS.. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
39. Tetraphenylethylene-based glycoclusters with aggregation-induced emission (AIE) properties as high-affinity ligands of bacterial lectins.
- Author
-
Donnier-Maréchal M, Abdullayev S, Bauduin M, Pascal Y, Fu MQ, He XP, Gillon E, Imberty A, Kipnis E, Dessein R, and Vidal S
- Subjects
- Ligands, Spectrometry, Fluorescence, Spectrophotometry, Ultraviolet, Adhesins, Bacterial metabolism, Oligosaccharides chemistry, Oligosaccharides metabolism, Stilbenes chemistry
- Abstract
Tetraphenylethylene (TPE) is fluorescent through aggregation induced emission (AIE) in water. Herein, TPE was used as the core of glycoclusters that target the bacterial lectins LecA and LecB of Pseudomonas aeruginosa. Synthesis of these TPE-based glycoclusters was accomplished by using azide-alkyne "click" chemistry. The AIE properties of the resulting glycoclusters could be readily verified, but imaging could not be pursued due to the overlap of the fluorescence signals from cells and bacteria. Nonetheless, the glycoclusters displayed nanomolar affinities toward LecA and LecB. Further evaluation in a cell-based anti-adhesive assay highlighted a limited decrease in adhesion (20%) for the fucosylated glycocluster. This confirmed that these TPE-based glycoclusters are indeed LecA and LecB high-affinity ligands. Nevertheless, the hypotheses involving their application in imaging or anti-adhesive therapy could not be verified.
- Published
- 2018
- Full Text
- View/download PDF
40. Early clindamycin for bacterial vaginosis in pregnancy (PREMEVA): a multicentre, double-blind, randomised controlled trial.
- Author
-
Subtil D, Brabant G, Tilloy E, Devos P, Canis F, Fruchart A, Bissinger MC, Dugimont JC, Nolf C, Hacot C, Gautier S, Chantrel J, Jousse M, Desseauve D, Plennevaux JL, Delaeter C, Deghilage S, Personne A, Joyez E, Guinard E, Kipnis E, Faure K, Grandbastien B, Ancel PY, Goffinet F, and Dessein R
- Subjects
- Adult, Double-Blind Method, Female, Humans, Pregnancy, Pregnancy Outcome, Abortion, Spontaneous prevention & control, Anti-Bacterial Agents therapeutic use, Clindamycin therapeutic use, Pregnancy Complications, Infectious drug therapy, Premature Birth prevention & control, Vaginosis, Bacterial drug therapy
- Abstract
Background: Preterm delivery during pregnancy (<37 weeks' gestation) is a leading cause of perinatal mortality and morbidity. Treating bacterial vaginosis during pregnancy can reduce poor outcomes, such as preterm birth. We aimed to investigate whether treatment of bacterial vaginosis decreases late miscarriages or spontaneous very preterm birth., Methods: PREMEVA was a double-blind randomised controlled trial done in 40 French centres. Women aged 18 years or older with bacterial vaginosis and low-risk pregnancy were eligible for inclusion and were randomly assigned (2:1) to three parallel groups: single-course or triple-course 300 mg clindamycin twice-daily for 4 days, or placebo. Women with high-risk pregnancy outcomes were eligible for inclusion in a high-risk subtrial and were randomly assigned (1:1) to either single-course or triple-course clindamycin. The primary outcome was a composite of late miscarriage (16-21 weeks) or spontaneous very preterm birth (22-32 weeks), which we assessed in all patients with delivery data (modified intention to treat). Adverse events were systematically reported. This study is registered with ClinicalTrials.gov, number NCT00642980., Findings: Between April 1, 2006, and June 30, 2011, we screened 84 530 pregnant women before 14 weeks' gestation. 5630 had bacterial vaginosis, of whom 3105 were randomly assigned to groups in the low-risk trial (n=943 to receive single-course clindamycin, n=968 to receive triple-course clindamycin, and n=958 to receive placebo) or high-risk subtrial (n=122 to receive single-course clindamycin and n=114 to receive triple-course clindamycin). In 2869 low-risk pregnancies, the primary outcome occurred in 22 (1·2%) of 1904 participants receiving clindamycin and 10 (1·0%) of 956 participants receiving placebo (relative risk [RR] 1·10, 95% CI 0·53-2·32; p=0·82). In 236 high-risk pregnancies, the primary outcome occurred in 5 (4·4%) participants in the triple-course clindamycin group and 8 (6·0%) participants in the single-course clindamycin group (RR 0·67, 95% CI 0·23-2·00; p=0·47). In the low-risk trial, adverse events were more common in the clindamycin groups than in the placebo group (58 [3·0%] of 1904 vs 12 [1·3%] of 956; p=0·0035). The most commonly reported adverse event was diarrhoea (30 [1·6%] in the clindamycin groups vs 4 [0·4%] in the placebo group; p=0·0071); abdominal pain was also observed in the clindamycin groups (9 [0·6%] participants) versus none in the placebo group (p=0·034). No severe adverse event was reported in any group. Adverse fetal and neonatal outcomes did not differ significantly between groups in the high-risk subtrial., Interpretation: Systematic screening and subsequent treatment for bacterial vaginosis in women with low-risk pregnancies shows no evidence of risk reduction of late miscarriage or spontaneous very preterm birth. Use of antibiotics to prevent preterm delivery in this patient population should be reconsidered., Funding: French Ministry of Health., (Copyright © 2018 Elsevier Ltd. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF
41. Draft Genome Sequences of Two Pseudomonas aeruginosa Multidrug-Resistant Clinical Isolates, PAL0.1 and PAL1.1.
- Author
-
Grandjean T, Le Guern R, Duployez C, Faure K, Kipnis E, and Dessein R
- Abstract
Pseudomonas aeruginosa infections are challenging due to intrinsic and acquired resistance mechanisms. We report here the draft genome sequences of two multidrug-resistant strains-PAL0.1, isolated from the airways of an intensive care unit (ICU) patient with ventilator-associated pneumonia, and PAL1.1, isolated from blood cultures of an ICU patient with sepsis.
- Published
- 2018
- Full Text
- View/download PDF
42. Draft Genome Sequences of Two Carbapenemase-Producing Klebsiella pneumoniae Strains Isolated from Blood Cultures.
- Author
-
Le Guern R, Grandjean T, Faure K, Bauduin M, Kipnis E, and Dessein R
- Abstract
Carbapenemase-producing Klebsiella pneumoniae represents an emerging public health issue. Here, we present the draft whole-genome sequences of K. pneumoniae clinical strains KPL0.1 (OXA-48 carbapenemase) and KPL0.2 (NDM-1 carbapenemase). These genome sequences should help in investigating pathophysiological mechanisms of digestive colonization or infection with these highly resistant bacteria.
- Published
- 2018
- Full Text
- View/download PDF
43. Extended-spectrum β-lactamase-producing Enterobacteriaceae, national study of antimicrobial treatment for pediatric urinary tract infection.
- Author
-
Lagree M, Bontemps S, Dessein R, Angoulvant F, Madhi F, Martinot A, Cohen R, and Dubos F
- Subjects
- Anti-Bacterial Agents pharmacology, Antimicrobial Stewardship, Bacterial Proteins analysis, Carbapenems therapeutic use, Child, Child, Preschool, Cross-Sectional Studies, Cystitis drug therapy, Cystitis microbiology, Drug Resistance, Multiple, Bacterial, Enterobacteriaceae drug effects, Enterobacteriaceae enzymology, Enterobacteriaceae Infections epidemiology, Enterobacteriaceae Infections microbiology, Female, France epidemiology, Hospitals, University statistics & numerical data, Humans, Inappropriate Prescribing, Male, Practice Patterns, Physicians', Pyelonephritis drug therapy, Pyelonephritis microbiology, Retrospective Studies, Secondary Care Centers statistics & numerical data, Surveys and Questionnaires, Urinary Tract Infections epidemiology, Urinary Tract Infections microbiology, beta-Lactam Resistance, beta-Lactamases analysis, Anti-Bacterial Agents therapeutic use, Enterobacteriaceae isolation & purification, Enterobacteriaceae Infections drug therapy, Urinary Tract Infections drug therapy
- Abstract
Objective: To evaluate clinical practices for ESBL-producing urinary tract infection (UTI) in France., Methods: We performed an observational, retrospective, cross-sectional, hospital-based study in 22 pediatric departments of university or secondary care hospitals. We collected data of the last five patients presenting with ESBL-producing UTI in 2012 and the physicians' therapeutic approach to two case vignettes of acute non-septic ESBL-producing pyelonephritis (7-month-old girl) and cystitis (30-month-old girl). The adequacy of the therapeutic decision was analyzed by a panel of independent infectious disease experts., Results: A total of 80 case patients of ESBL-producing UTI were collected: 54 with acute pyelonephritis (mean age: 28 months, female: 66%), of whom 98% received an intravenous ESBL-adapted antibiotic treatment and 55% a two-drug antibiotic therapy. Carbapenems were used in 56% of cases and aminoglycosides in 36%. Of the 26 cystitis patients (mean age: 5 years, female: 73%), 85% were treated with antibiotics, including three intravenously (carbapenems=2). For the case vignettes, physicians (n=85) would have treated the pyelonephritis patient with carbapenems (76%) and/or aminoglycosides (68%); 71% would have used a two-drug antibiotic treatment. The cystitis patient would have been treated intravenously by 29% of physicians; 8% would have used a two-drug antibiotic treatment, 16% would have prescribed carbapenems, and 11% aminoglycosides. Antibiotic treatments were deemed appropriate in 37% of cases., Conclusions: Antimicrobial treatment for ESBL-producing UTI greatly varies, and carbapenems are excessively prescribed. Specific guidelines for ESBL infections are required., (Copyright © 2018 Elsevier Masson SAS. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF
44. Perylenediimide-based glycoclusters as high affinity ligands of bacterial lectins: synthesis, binding studies and anti-adhesive properties.
- Author
-
Donnier-Maréchal M, Galanos N, Grandjean T, Pascal Y, Ji DK, Dong L, Gillon E, He XP, Imberty A, Kipnis E, Dessein R, and Vidal S
- Subjects
- Binding Sites drug effects, Calorimetry, Cell Adhesion drug effects, Glycoconjugates chemical synthesis, Glycoconjugates chemistry, Imides chemical synthesis, Imides chemistry, Ligands, Molecular Structure, Perylene chemical synthesis, Perylene chemistry, Perylene pharmacology, Pseudomonas aeruginosa chemistry, Pseudomonas aeruginosa cytology, Adhesins, Bacterial drug effects, Glycoconjugates pharmacology, Imides pharmacology, Lectins antagonists & inhibitors, Perylene analogs & derivatives, Pseudomonas aeruginosa drug effects
- Abstract
The synthesis of eight perylenediimide-based glycoclusters was readily performed from hexa- and tetra-propargylated cores through azide-alkyne "click" conjugation. Variations in the carbohydrate epitope (Glc, Gal, Man, Fuc) and the linker arm provided molecular diversity. Interactions with LecA and LecB, two proteins involved in the adhesion of Pseudomonas aeruginosa to host tissues, were evaluated by microcalorimetry (ITC). In both cases high affinities were obtained with K
d values in the nanomolar range. Further evaluation of their anti-adhesive properties using cultured epithelial cells demonstrated their potent anti-adhesive activities against Pseudomonas aeruginosa with only 30-40% residual adhesion observed. The fluorescence properties of the PDI core were then investigated by confocal microscopy on cell-bacteria cultures. However, the red fluorescence signal of the PDI-based glycocluster was too weak to provide significant data. The present study provides another type of anti-adhesive glycocluster against bacterial infection with a large aromatic PDI core.- Published
- 2017
- Full Text
- View/download PDF
45. Diagnosis of primary antibody and complement deficiencies in young adults after a first invasive bacterial infection.
- Author
-
Sanges S, Wallet F, Blondiaux N, Theis D, Vérin I, Vachée A, Dessein R, Faure K, Viget N, Senneville E, Leroy O, Maury F, Just N, Poissy J, Mathieu D, Prévotat A, Chenivesse C, Scherpereel A, Smith G, Lopez B, Rosain J, Frémeaux-Bacchi V, Hachulla E, Hatron PY, Bahuaud M, Batteux F, Launay D, Labalette M, and Lefèvre G
- Subjects
- Adolescent, Adult, Female, Humans, Immunologic Factors deficiency, Male, Mass Screening methods, Prevalence, Retrospective Studies, Young Adult, Bacteremia etiology, Bacteremia immunology, Complement System Proteins deficiency, Immunologic Deficiency Syndromes complications, Immunologic Deficiency Syndromes diagnosis, Meningitis, Bacterial etiology, Meningitis, Bacterial immunology
- Abstract
Objectives: Screening for primary immunodeficiencies (PIDs) in adults is recommended after two severe bacterial infections. We aimed to evaluate if screening should be performed after the first invasive infection in young adults., Methods: Eligible patients were retrospectively identified using hospital discharge and bacteriology databases in three centres during a 3-year period. Eighteen to 40-year-old patients were included if they had experienced an invasive infection with encapsulated bacteria commonly encountered in PIDs (Streptococcus pneumoniae (SP), Neisseria meningitidis (NM), Neisseria gonorrhoeae (NG), Haemophilus influenzae (HI), or group A Streptococcus (GAS)). They were excluded in case of general or local predisposing factors. Immunological explorations and PIDs diagnoses were retrieved from medical records. Serum complement and IgG/A/M testings were systematically proposed at the time of study to patients with previously incomplete PID screening., Results: The study population comprised 38 patients. Thirty-six had experienced a first invasive episode and a PID was diagnosed in seven (19%): two cases of common variable immunodeficiency revealed by SP bacteraemia, one case of idiopathic primary hypogammaglobulinaemia, and two cases of complement (C6 and C7) deficiency revealed by NM meningitis, one case of IgG2/IgG4 subclasses deficiency revealed by GAS bacteraemia, and one case of specific polysaccharide antibody deficiency revealed by HI meningitis. Two patients had previously experienced an invasive infection before the study period: in both cases, a complement deficiency was diagnosed after a second NM meningitis and a second NG bacteraemia, respectively., Conclusion: PID screening should be considered after a first unexplained invasive encapsulated-bacterial infection in young adults., (Copyright © 2017 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.)
- Published
- 2017
- Full Text
- View/download PDF
46. The human NAIP-NLRC4-inflammasome senses the Pseudomonas aeruginosa T3SS inner-rod protein.
- Author
-
Grandjean T, Boucher A, Thepaut M, Monlezun L, Guery B, Faudry E, Kipnis E, and Dessein R
- Subjects
- Animals, Carrier Proteins metabolism, Caspase 1 metabolism, Humans, Immunity, Innate, Intercellular Signaling Peptides and Proteins, Interleukin-1beta metabolism, Macrophages microbiology, Mice, Pathogen-Associated Molecular Pattern Molecules immunology, THP-1 Cells, Toll-Like Receptor 2 metabolism, Toll-Like Receptor 4 metabolism, Type III Secretion Systems immunology, CARD Signaling Adaptor Proteins metabolism, Calcium-Binding Proteins metabolism, Inflammasomes metabolism, Macrophages immunology, Neuronal Apoptosis-Inhibitory Protein metabolism, Pseudomonas Infections immunology, Pseudomonas aeruginosa immunology, Type III Secretion Systems metabolism
- Abstract
While NLRC4-dependent sensing of intracellular Gram-negative pathogens such as Salmonella enterica serovar typhimurium is a beneficial host response, NLRC4-dependent sensing of the Pseudomonas aeruginosa type 3 secretion system (T3SS) has been shown to be involved in pathogenicity. In mice, different pathogen-associated microbial patterns are sensed by the combination of the NLRC4-inflammasome with different neuronal apoptosis inhibitory proteins (NAIPs). NAIP2 is involved in sensing PscI, an inner-rod protein of the P. aeruginosa T3SS. Surprisingly, only a single human NAIP (hNAIP) has been found. Moreover, there is no description of hNAIP-NLRC4 inflammasome recognition of T3SS inner-rod proteins in humans. Here, we show that the P. aeruginosa T3SS inner-rod protein PscI and needle protein PscF are both sensed by the hNAIP-NLRC4 inflammasome in human macrophages and PBMCs from healthy donors, allowing caspase-1 and IL-1β maturation and resulting in a robust inflammatory response. TLR4 and TLR2 are involved in redundantly sensing these two T3SS components., (© The Japanese Society for Immunology. 2017. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.)
- Published
- 2017
- Full Text
- View/download PDF
47. Tryptophan catabolism in Pseudomonas aeruginosa and potential for inter-kingdom relationship.
- Author
-
Bortolotti P, Hennart B, Thieffry C, Jausions G, Faure E, Grandjean T, Thepaut M, Dessein R, Allorge D, Guery BP, Faure K, Kipnis E, Toussaint B, and Le Gouellec A
- Subjects
- Acute Lung Injury microbiology, Animals, Disease Models, Animal, Host-Pathogen Interactions, Immunity, Innate, Kynurenic Acid metabolism, Kynurenine metabolism, Metabolic Networks and Pathways, Mice, Murinae, Pseudomonas Infections immunology, Pseudomonas Infections microbiology, Pseudomonas aeruginosa enzymology, Transaminases metabolism, ortho-Aminobenzoates metabolism, Pseudomonas aeruginosa metabolism, Tryptophan metabolism
- Abstract
Background: Pseudomonas aeruginosa (Pa) is a Gram-negative bacteria frequently involved in healthcare-associated pneumonia with poor clinical outcome. To face the announced post-antibiotic era due to increasing resistance and lack of new antibiotics, new treatment strategies have to be developed. Immunomodulation of the host response involved in outcome could be an alternative therapeutic target in Pa-induced lung infection. Kynurenines are metabolites resulting from tryptophan catabolism and are known for their immunomodulatory properties. Pa catabolizes tryptophan through the kynurenine pathway. Interestingly, many host cells also possess the kynurenine pathway, whose metabolites are known to control immune system homeostasis. Thus, bacterial metabolites may interfere with the host's immune response. However, the kynurenine pathway in Pa, including functional enzymes, types and amounts of secreted metabolites remains poorly known. Using liquid chromatography coupled to mass spectrometry and different strains of Pa, we determined types and levels of metabolites produced by Pa ex vivo in growth medium, and the relevance of this production in vivo in a murine model of acute lung injury., Results: Ex vivo, Pa secretes clinically relevant kynurenine levels (μM to mM). Pa also secretes kynurenic acid and 3-OH-kynurenine, suggesting that the bacteria possess both a functional kynurenine aminotransferase and kynurenine monooxygenase. The bacterial kynurenine pathway is the major pathway leading to anthranilate production both ex vivo and in vivo. In the absence of the anthranilate pathway, the kynurenine pathway leads to kynurenic acid production., Conclusion: Pa produces and secretes several metabolites of the kynurenine pathway. Here, we demonstrate the existence of new metabolic pathways leading to synthesis of bioactive molecules, kynurenic acid and 3-OH-kynurenine in Pa. The kynurenine pathway in Pa is critical to produce anthranilate, a crucial precursor of some Pa virulence factors. Metabolites (anthranilate, kynurenine, kynurenic acid) are produced at sustained levels both ex vivo and in vivo leading to a possible immunomodulatory interplay between bacteria and host. These data may imply that pulmonary infection with bacteria highly expressing the kynurenine pathway enzymes could influence the equilibrium of the host's tryptophan metabolic pathway, known to be involved in the immune response to infection. Further studies are needed to explore the effects of these metabolic changes on the pathophysiology of Pa infection.
- Published
- 2016
- Full Text
- View/download PDF
48. Cefoxitin: An alternative to carbapenems in urinary tract infections due to extended-spectrum beta-lactamase-producing Enterobacteriaceae.
- Author
-
Mambie A, Vuotto F, Poitrenaud D, Weyrich P, Cannesson O, Dessein R, Faure K, Guery B, and Galpérine T
- Subjects
- Anti-Bacterial Agents adverse effects, Bacterial Proteins metabolism, Cefoxitin adverse effects, Drug Eruptions etiology, Female, Humans, Klebsiella Infections drug therapy, Klebsiella pneumoniae drug effects, Klebsiella pneumoniae enzymology, Male, Middle Aged, Prospective Studies, Treatment Outcome, Uropathogenic Escherichia coli drug effects, Uropathogenic Escherichia coli enzymology, beta-Lactamases metabolism, Anti-Bacterial Agents therapeutic use, Cefoxitin therapeutic use, Escherichia coli Infections drug therapy, Urinary Tract Infections drug therapy, beta-Lactam Resistance
- Abstract
Background and Objectives: Infections caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-E) have become a major public health issue worldwide. Cefoxitin is a second-generation cephalosporin and is associated with a strong in vitro activity against ESBL., Patients and Methods: We conducted a prospective monocentric cohort study from 2012 to 2015 to evaluate the clinical efficacy and safety of cefoxitin in 15 patients treated for urinary tract infection (UTI) caused by ESBL-E, without any severity criteria., Results: We included 15 patients; 11 were male patients with defined risk factors for ESBL-E. Ten patients presented with male UTI, three with pyelonephritis, and two with cystitis. Escherichia coli was the predominant pathogen. All patients had a positive outcome with a good tolerance (a skin rash without any sign of severity was observed in one patient). Microbiological cure was obtained in 9 patients out of 10 at the end of treatment., Conclusion: Cefoxitin is an alternative treatment to carbapenems for urinary tract infections caused by ESBL-producing Enterobacteriaceae., (Copyright © 2016 Elsevier Masson SAS. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF
49. [Tubo-ovarian abscesses treatment: Faisability and results of trans-vaginal ultrasound-guided aspiration].
- Author
-
Vermersch C, Dessein R, Lucot JP, Rubod C, Cosson M, and Giraudet G
- Subjects
- Abscess epidemiology, Abscess microbiology, Adolescent, Adult, Anti-Bacterial Agents therapeutic use, Drainage adverse effects, Fallopian Tube Diseases epidemiology, Fallopian Tube Diseases microbiology, Feasibility Studies, Female, Humans, Middle Aged, Ovarian Diseases epidemiology, Ovarian Diseases microbiology, Postoperative Complications epidemiology, Treatment Outcome, Ultrasonography, Interventional adverse effects, Vagina diagnostic imaging, Vagina microbiology, Young Adult, Abscess therapy, Drainage methods, Fallopian Tube Diseases therapy, Ovarian Diseases therapy, Ultrasonography, Interventional methods
- Abstract
Objective: Two years after the French guidelines, the objective was to assess the feasibility and efficiency of ultrasound-guided trans-vaginal drainage of tubo-ovarian abscesses (TOA) and to study the responsible germs., Material and Methods: All the patients with a larger abscess than 20mm were included prospectively from May 2011 to July 2014 in the university hospital of Lille., Results: Sixty-nine drainages were performed among 50 patients. Success rate was 94%. No complication occurred. One germ was found in 55% of patients, the TOA was polymicrobian in 20% of cases., Conclusion: Ultrasound-guided trans-vaginal drainage of TOA is safe and effective with more than 90% of success rate., (Copyright © 2015 Elsevier Masson SAS. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF
50. Impact of the 13-valent pneumococcal conjugate vaccine on the incidence of pneumococcal meningitis in children.
- Author
-
Chapoutot AG, Dessein R, Guilluy O, Lagrée M, Wallet F, Varon E, Martinot A, and Dubos F
- Subjects
- Child, Child, Preschool, Databases, Factual, Female, France epidemiology, Humans, Incidence, Infant, Infant, Newborn, Interrupted Time Series Analysis, Male, Retrospective Studies, Serogroup, Vaccines, Conjugate, Meningitis, Pneumococcal epidemiology, Meningitis, Pneumococcal prevention & control, Pneumococcal Vaccines, Streptococcus pneumoniae classification
- Abstract
The impact of the 13-valent pneumococcal conjugate vaccine (PCV13) on the incidence of pneumococcal meningitis (PM) in children is unknown. To determine this impact, a descriptive multicentre retrospective cohort study was conducted from 2008 to 2013 in northern France. All laboratory-confirmed PM in children aged <18 years in all hospitals of the area with paediatric units were included. Two independent databases were used for exhaustive identification of cases: medical plus laboratory records at each hospital and discharge codes. The corrected incidence of PM was determined by a capture-recapture analysis using these two databases. Sixty-two cases were found over the 6-year period. A decrease of the PM corrected incidence was observed in the global population (P = 0·07), significant only for children aged <2 years, from 11·9/100 000 in 2008 in 1·9/100 000 in 2013 [6·4 fold-decrease, 95% confidence interval (CI) 1·4-41, P = 0·01] between years 2008 and 2013. When comparing the pre- and post-PCV13 periods, this decrease was still statistically significant for children aged <2 years [7·32/100 000 (95% CI 4·39-10·25) to 2·78/100 000 (95% CI 0·96-4·60), P = 0·01]. Only three (5%) cases of PM caused by vaccine serotypes could have been prevented. After the introduction of the PCV13 vaccine, a decrease in the incidence of PM cases in children in northern France was observed.
- Published
- 2016
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.